JAMA Neurology · Published 2026-08-03 · DOI 10.1001/jamaneurol.2026.2500
Maximilian Einsiedler, Sofia Sandgren, Sabine Schaedelin, Kiarra Ning, Aleksandra Maleska Maceski, Johanna Oechtering, Christian Cordano, Lester Melie-Garcia, Jeffrey M. Gelfand, Alessandro Cagol, Roland G. Henry, Sebastian Finkener, Patrice H. Lalive, Stefanie Müller, Caroline Pot, Amandine Mathias, Renaud Du Pasquier, Robert Hoepner, Andrew Chan, Giulio Disanto, Chiara Zecca, Marcus D’Souza, Lars G. Hemkens, Özgür Yaldizli, Bettina Fischer-Barnicol, Tobias Derfuss, Patrick Roth, Marina Herwerth, Claudio Gobbi, David Brassat, Björn Tackenberg, Rosetta Pedotti, Heinz Wiendl, Klaus Berger, Marco Hermesdorf, Georgina Arrambide, Fredrik Piehl, Henrik Zetterberg, Bruce A.C. Cree, Maria Pia Sormani, Ludwig Kappos, Stephen L. Hauser, Michael Khalil, Cristina Granziera, Ari J. Green, David Leppert, Pascal Benkert, Ahmed Abdelhak, Jens Kuhle, Expression, Proteomics, Imaging, Clinical (EPIC) study and the Swiss MS Cohort (SMSC) investigators, Lisa Hofer, Michelle Hughes, Nafiye Genc, Amar Zadic, Juan Francisco Vilchez Gomez, Riccardo Galbusera, Edoardo Galli, Jannis Müller, Marjolaine Uginet, Veronika Kana, Catarina Raposo, Jorge Oksenberg, David Conen
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Einsiedler, M., Sandgren, S., Schaedelin, S., et al. (2026). Serum Glial Fibrillary Acidic Protein Dynamics, Disease Progression, and Therapy Response in Multiple Sclerosis. JAMA Neurology. https://doi.org/10.1001/jamaneurol.2026.2500